» Articles » PMID: 31559963

BPaL Approved for Multidrug-resistant Tuberculosis

Overview
Date 2019 Sep 28
PMID 31559963
Citations 10
Authors
Affiliations
Soon will be listed here.
Citing Articles

Enhancing the therapeutic window for Spectinamide anti-tuberculosis Agents: Synthesis, Evaluation, and activation of phosphate prodrug 3408.

Liu J, Lukka P, Ektnitphong V, Parmar K, Wagh S, Lu Y Bioorg Med Chem Lett. 2024; 112:129934.

PMID: 39214506 PMC: 11403708. DOI: 10.1016/j.bmcl.2024.129934.


Indazole to 2-Cyanoindole Scaffold Progression for Mycobacterial Lipoamide Dehydrogenase Inhibitors Achieves Extended Target Residence Time and Improved Antibacterial Activity.

Sun S, Ginn J, Kochanczyk T, Arango N, Jiang X, Huggins D Angew Chem Int Ed Engl. 2024; 63(44):e202407276.

PMID: 38997232 PMC: 11887847. DOI: 10.1002/anie.202407276.


Bactericidal and sterilizing activity of sudapyridine-clofazimine-TB47 combined with linezolid or pyrazinamide in a murine model of tuberculosis.

Yu W, Ju Y, Han X, Tian X, Ding J, Wang S Antimicrob Agents Chemother. 2024; 68(6):e0012424.

PMID: 38690893 PMC: 11620513. DOI: 10.1128/aac.00124-24.


Integrative analysis of multimodal patient data identifies personalized predictors of tuberculosis treatment prognosis.

Sambarey A, Smith K, Chung C, Arora H, Yang Z, Agarwal P iScience. 2024; 27(2):109025.

PMID: 38357663 PMC: 10865408. DOI: 10.1016/j.isci.2024.109025.


Application of Chiral Transfer Reagents to Improve Stereoselectivity and Yields in the Synthesis of the Antituberculosis Drug Bedaquiline.

Robey J, Maity S, Aleshire S, Ghosh A, Yadaw A, Roy S Org Process Res Dev. 2023; 27(11):2146-2159.

PMID: 38025988 PMC: 10661061. DOI: 10.1021/acs.oprd.3c00287.